DNA

Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025

Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology…

5 months ago

Hydreight Technologies Signs Binding Letter of Intent to Acquire Dynamic IV Therapy Support AI Agent

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Sept. 08, 2025…

5 months ago

ElevateBio Appoints Larry Lockwood, Ph.D., as Chief Commercial Officer

Dr. Lockwood brings more than 20 years of experience driving revenue growth and establishing global partnerships for manufacturing and research…

5 months ago

Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database

5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partnersNew hospital-based data seeks to further differentiate pending kitted…

5 months ago

IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants

iMDx’s ClinicalTrials.gov listing now names 10 leading transplant centers, up from 5 previouslyGraftAssureDx remains on track for FDA submission by…

5 months ago

Ocular Therapeutix™ to Host Investor Day on September 30, 2025

Company to highlight ongoing AXPAXLI™ wet AMD registrational program, strategy and next steps in NPDR and DME, and global commercial…

5 months ago

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5…

5 months ago

Lung Cancer Genetics Study Launches Open-Source Data Platform to Research Community

No-cost access available to qualified researchers via open-source federated data platformSAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research…

5 months ago

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

BOSTON and ROLLE, Switzerland, Sept. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader…

5 months ago

Teal Health is Now Available in New York and Florida, Meeting Rising Demand for At-Home Cervical Cancer Screening

Following their California launch last month, Teal is expanding to bring at-home cervical cancer screening to millions more women. SAN…

5 months ago